Nancy Simonian
2020
In 2020, Nancy Simonian earned a total compensation of $2.5M as President & Chief Executive Officer at Syros Pharmaceuticals, a 30% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $429,000 |
|---|---|
| Option Awards | $1,503,457 |
| Salary | $597,692 |
| Other | $360 |
| Total | $2,530,509 |
Simonian received $1.5M in option awards, accounting for 59% of the total pay in 2020.
Simonian also received $429K in non-equity incentive plan, $597.7K in salary and $360 in other compensation.
Rankings
In 2020, Nancy Simonian's compensation ranked 4,496th out of 13,090 executives tracked by ExecPay. In other words, Simonian earned more than 65.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,496 out of 13,090 | 66th |
Division Manufacturing | 1,818 out of 5,621 | 68th |
Major group Chemicals And Allied Products | 704 out of 2,254 | 69th |
Industry group Drugs | 603 out of 1,954 | 69th |
Industry Pharmaceutical Preparations | 458 out of 1,459 | 69th |
Source: SEC filing on April 29, 2021.
Simonian's colleagues
We found two more compensation records of executives who worked with Nancy Simonian at Syros Pharmaceuticals in 2020.
News
Syros Pharmaceuticals CEO Nancy Simonian's 2023 pay falls 59% to $1.4M
April 23, 2024
Syros Pharmaceuticals CEO Nancy Simonian's 2022 pay rises 12% to $3.5M
April 21, 2023
Syros Pharmaceuticals CEO Nancy Simonian's 2021 pay jumps 23% to $3.1M
April 21, 2022
Syros Pharmaceuticals CEO Nancy Simonian's 2020 pay falls 30% to $2.5M
April 29, 2021
Syros Pharmaceuticals CEO Nancy Simonian's 2019 pay rises 19% to $3.6M
April 28, 2020
Syros Pharmaceuticals CEO Nancy Simonian's 2018 pay jumps 36% to $3M
April 25, 2019